Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keri S Chaney

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Dermatology|March 5, 2013
Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphomaJennifer A DeSimone, Emmanuella Guenova, Joi B Carter, et al.
Science Translational Medicine|January 21, 2012
Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patientsRachael A Clark, Rei Watanabe, Jessica E Teague, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Dermatology|March 5, 2013
Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphomaJennifer A DeSimone, Emmanuella Guenova, Joi B Carter, et al.
Science Translational Medicine|January 21, 2012
Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patientsRachael A Clark, Rei Watanabe, Jessica E Teague, et al.
Pageof 1